Global IMP4279 Market Growth 2026-2032
The global IMP4279 market size is predicted to grow from US$ 2.93 million in 2025 to US$ 49.85 million in 2032; it is expected to grow at a CAGR of 9.2% from 2026 to 2032.
IMP4279 is a novel DNA damage response pathway inhibitor independently developed by Impact Therapeutics at the preclinical research stage, focusing on exploring unmet clinical needs in the field of oncology. Designed and optimized based on the company?s technological expertise in DDR inhibitor platforms, this compound exhibits high target selectivity and favorable druggability. It aims to inhibit tumor cell proliferation and enhance the sensitivity of other antineoplastic therapies by interfering with the DNA repair mechanism of tumor cells. As an investigational innovative small-molecule drug, IMP4279 has not yet entered clinical trials, and its mechanism of action, safety profile, and efficacy are still being continuously verified in preclinical models. In the future, it is expected to be used as a single agent or in combination with chemotherapy, targeted therapy, and immunotherapy for the treatment of various solid tumors, providing new potential therapeutic options for patients with malignant tumors.In 2025, global IMP4279 production reached approximately 2,000 vials.
As a novel preclinical DDR pathway inhibitor, IMP4279 operates within a rapidly expanding global oncology market driven by unmet medical needs and the growing adoption of targeted therapies. The broader DNA damage repair (DDR) inhibitor sector, underpinned by the synthetic lethality mechanism, has gained significant traction, establishing itself as a high-growth and strategically vital segment within precision oncology. This market landscape is characterized by a robust pipeline of innovative agents, a shift towards novel targets beyond established PARP inhibitors, and an increasing emphasis on combination regimens to overcome treatment resistance and enhance efficacy. Positioned at the forefront of this trend, IMP4279 benefits from the favorable industry dynamics and the proven commercial success of earlier DDR drugs. Its clinical-stage potential is underscored by the strong market demand for next-generation treatments that offer improved selectivity, safety profiles, and the ability to synergize with existing chemo-, targeted, and immunotherapies. Despite being in the preclinical phase, IMP4279 holds considerable market promise, targeting a broad spectrum of solid tumors where current standards of care are limited. Its development aligns with the global pharmaceutical industry's strategic focus on first-in-class and best-in-class molecules, which command premium pricing and significant market penetration upon successful launch.While competitive pressures are intensifying as more players enter the DDR space, IMP4279's distinct mechanism of action and early-stage positioning provide a valuable opportunity to capture future market share. Successful clinical advancement would allow IMP4279 to address the persistent gaps in cancer care, solidifying its role as a key component in the next wave of transformative oncological therapies and securing a strong commercial foothold in the expanding global DDR inhibitor market.
LP Information, Inc. (LPI) ' newest research report, the ?IMP4279 Industry Forecast? looks at past sales and reviews total world IMP4279 sales in 2025, providing a comprehensive analysis by region and market sector of projected IMP4279 sales for 2026 through 2032. With IMP4279 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IMP4279 industry.
This Insight Report provides a comprehensive analysis of the global IMP4279 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IMP4279 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global IMP4279 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IMP4279 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IMP4279.
This report presents a comprehensive overview, market shares, and growth opportunities of IMP4279 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global IMP4279 market?
What factors are driving IMP4279 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IMP4279 market opportunities vary by end market size?
How does IMP4279 break out by Type, by Application?
IMP4279 is a novel DNA damage response pathway inhibitor independently developed by Impact Therapeutics at the preclinical research stage, focusing on exploring unmet clinical needs in the field of oncology. Designed and optimized based on the company?s technological expertise in DDR inhibitor platforms, this compound exhibits high target selectivity and favorable druggability. It aims to inhibit tumor cell proliferation and enhance the sensitivity of other antineoplastic therapies by interfering with the DNA repair mechanism of tumor cells. As an investigational innovative small-molecule drug, IMP4279 has not yet entered clinical trials, and its mechanism of action, safety profile, and efficacy are still being continuously verified in preclinical models. In the future, it is expected to be used as a single agent or in combination with chemotherapy, targeted therapy, and immunotherapy for the treatment of various solid tumors, providing new potential therapeutic options for patients with malignant tumors.In 2025, global IMP4279 production reached approximately 2,000 vials.
As a novel preclinical DDR pathway inhibitor, IMP4279 operates within a rapidly expanding global oncology market driven by unmet medical needs and the growing adoption of targeted therapies. The broader DNA damage repair (DDR) inhibitor sector, underpinned by the synthetic lethality mechanism, has gained significant traction, establishing itself as a high-growth and strategically vital segment within precision oncology. This market landscape is characterized by a robust pipeline of innovative agents, a shift towards novel targets beyond established PARP inhibitors, and an increasing emphasis on combination regimens to overcome treatment resistance and enhance efficacy. Positioned at the forefront of this trend, IMP4279 benefits from the favorable industry dynamics and the proven commercial success of earlier DDR drugs. Its clinical-stage potential is underscored by the strong market demand for next-generation treatments that offer improved selectivity, safety profiles, and the ability to synergize with existing chemo-, targeted, and immunotherapies. Despite being in the preclinical phase, IMP4279 holds considerable market promise, targeting a broad spectrum of solid tumors where current standards of care are limited. Its development aligns with the global pharmaceutical industry's strategic focus on first-in-class and best-in-class molecules, which command premium pricing and significant market penetration upon successful launch.While competitive pressures are intensifying as more players enter the DDR space, IMP4279's distinct mechanism of action and early-stage positioning provide a valuable opportunity to capture future market share. Successful clinical advancement would allow IMP4279 to address the persistent gaps in cancer care, solidifying its role as a key component in the next wave of transformative oncological therapies and securing a strong commercial foothold in the expanding global DDR inhibitor market.
LP Information, Inc. (LPI) ' newest research report, the ?IMP4279 Industry Forecast? looks at past sales and reviews total world IMP4279 sales in 2025, providing a comprehensive analysis by region and market sector of projected IMP4279 sales for 2026 through 2032. With IMP4279 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IMP4279 industry.
This Insight Report provides a comprehensive analysis of the global IMP4279 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IMP4279 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global IMP4279 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IMP4279 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IMP4279.
This report presents a comprehensive overview, market shares, and growth opportunities of IMP4279 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 10mg
- 50mg
- Freeze-Dried Powder for Injection
- Capsule
- Oral Administration
- Intravenous Injection
- Hospital
- Retail
- Online
- Peripheral T-Cell Lymphoma (PTCL)
- Relapsed Or Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
- T-Cell Hematologic Malignancies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Nanjing IMPACT Therapeutics
What is the 10-year outlook for the global IMP4279 market?
What factors are driving IMP4279 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IMP4279 market opportunities vary by end market size?
How does IMP4279 break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global IMP4279 Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for IMP4279 by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for IMP4279 by Country/Region, 2021, 2025 & 2032
2.2 IMP4279 Segment by Type
2.2.1 10mg
2.2.2 50mg
2.2.3 IMP4279 Sales by Type
2.2.3.1 Global IMP4279 Sales Market Share by Type (2021-2026)
2.2.3.2 Global IMP4279 Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global IMP4279 Sale Price by Type (2021-2026)
2.3 IMP4279 Segment by Dosage Form
2.3.1 Freeze-Dried Powder for Injection
2.3.2 Capsule
2.3.3 IMP4279 Sales by Dosage Form
2.3.3.1 Global IMP4279 Sales Market Share by Dosage Form (2021-2026)
2.3.3.2 Global IMP4279 Revenue and Market Share by Dosage Form (2021-2026)
2.3.3.3 Global IMP4279 Sale Price by Dosage Form (2021-2026)
2.4 IMP4279 Segment by Route of Administration
2.4.1 Oral Administration
2.4.2 Intravenous Injection
2.4.3 IMP4279 Sales by Route of Administration
2.4.3.1 Global IMP4279 Sales Market Share by Route of Administration (2021-2026)
2.4.3.2 Global IMP4279 Revenue and Market Share by Route of Administration (2021-2026)
2.4.3.3 Global IMP4279 Sale Price by Route of Administration (2021-2026)
2.5 IMP4279 Segment by Sales Channels
2.5.1 Hospital
2.5.2 Retail
2.5.3 Online
2.5.4 IMP4279 Sales by Sales Channels
2.5.4.1 Global IMP4279 Sales Market Share by Sales Channels (2021-2026)
2.5.4.2 Global IMP4279 Revenue and Market Share by Sales Channels (2021-2026)
2.5.4.3 Global IMP4279 Sale Price by Sales Channels (2021-2026)
2.6 IMP4279 Segment by Application
2.6.1 Peripheral T-Cell Lymphoma (PTCL)
2.6.2 Relapsed Or Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
2.6.3 T-Cell Hematologic Malignancies
2.6.4 Others
2.6.5 IMP4279 Sales by Application
2.6.5.1 Global IMP4279 Sale Market Share by Application (2021-2026)
2.6.5.2 Global IMP4279 Revenue and Market Share by Application (2021-2026)
2.6.5.3 Global IMP4279 Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global IMP4279 Breakdown Data by Company
3.1.1 Global IMP4279 Annual Sales by Company (2021-2026)
3.1.2 Global IMP4279 Sales Market Share by Company (2021-2026)
3.2 Global IMP4279 Annual Revenue by Company (2021-2026)
3.2.1 Global IMP4279 Revenue by Company (2021-2026)
3.2.2 Global IMP4279 Revenue Market Share by Company (2021-2026)
3.3 Global IMP4279 Sale Price by Company
3.4 Key Manufacturers IMP4279 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IMP4279 Product Location Distribution
3.4.2 Players IMP4279 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IMP4279 BY GEOGRAPHIC REGION
4.1 World Historic IMP4279 Market Size by Geographic Region (2021-2026)
4.1.1 Global IMP4279 Annual Sales by Geographic Region (2021-2026)
4.1.2 Global IMP4279 Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic IMP4279 Market Size by Country/Region (2021-2026)
4.2.1 Global IMP4279 Annual Sales by Country/Region (2021-2026)
4.2.2 Global IMP4279 Annual Revenue by Country/Region (2021-2026)
4.3 Americas IMP4279 Sales Growth
4.4 APAC IMP4279 Sales Growth
4.5 Europe IMP4279 Sales Growth
4.6 Middle East & Africa IMP4279 Sales Growth
5 AMERICAS
5.1 Americas IMP4279 Sales by Country
5.1.1 Americas IMP4279 Sales by Country (2021-2026)
5.1.2 Americas IMP4279 Revenue by Country (2021-2026)
5.2 Americas IMP4279 Sales by Type (2021-2026)
5.3 Americas IMP4279 Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IMP4279 Sales by Region
6.1.1 APAC IMP4279 Sales by Region (2021-2026)
6.1.2 APAC IMP4279 Revenue by Region (2021-2026)
6.2 APAC IMP4279 Sales by Type (2021-2026)
6.3 APAC IMP4279 Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe IMP4279 by Country
7.1.1 Europe IMP4279 Sales by Country (2021-2026)
7.1.2 Europe IMP4279 Revenue by Country (2021-2026)
7.2 Europe IMP4279 Sales by Type (2021-2026)
7.3 Europe IMP4279 Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa IMP4279 by Country
8.1.1 Middle East & Africa IMP4279 Sales by Country (2021-2026)
8.1.2 Middle East & Africa IMP4279 Revenue by Country (2021-2026)
8.2 Middle East & Africa IMP4279 Sales by Type (2021-2026)
8.3 Middle East & Africa IMP4279 Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IMP4279
10.3 Manufacturing Process Analysis of IMP4279
10.4 Industry Chain Structure of IMP4279
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IMP4279 Distributors
11.3 IMP4279 Customer
12 WORLD FORECAST REVIEW FOR IMP4279 BY GEOGRAPHIC REGION
12.1 Global IMP4279 Market Size Forecast by Region
12.1.1 Global IMP4279 Forecast by Region (2027-2032)
12.1.2 Global IMP4279 Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global IMP4279 Forecast by Type (2027-2032)
12.7 Global IMP4279 Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Nanjing IMPACT Therapeutics
13.1.1 Nanjing IMPACT Therapeutics Company Information
13.1.2 Nanjing IMPACT Therapeutics IMP4279 Product Portfolios and Specifications
13.1.3 Nanjing IMPACT Therapeutics IMP4279 Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Nanjing IMPACT Therapeutics Main Business Overview
13.1.5 Nanjing IMPACT Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global IMP4279 Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for IMP4279 by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for IMP4279 by Country/Region, 2021, 2025 & 2032
2.2 IMP4279 Segment by Type
2.2.1 10mg
2.2.2 50mg
2.2.3 IMP4279 Sales by Type
2.2.3.1 Global IMP4279 Sales Market Share by Type (2021-2026)
2.2.3.2 Global IMP4279 Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global IMP4279 Sale Price by Type (2021-2026)
2.3 IMP4279 Segment by Dosage Form
2.3.1 Freeze-Dried Powder for Injection
2.3.2 Capsule
2.3.3 IMP4279 Sales by Dosage Form
2.3.3.1 Global IMP4279 Sales Market Share by Dosage Form (2021-2026)
2.3.3.2 Global IMP4279 Revenue and Market Share by Dosage Form (2021-2026)
2.3.3.3 Global IMP4279 Sale Price by Dosage Form (2021-2026)
2.4 IMP4279 Segment by Route of Administration
2.4.1 Oral Administration
2.4.2 Intravenous Injection
2.4.3 IMP4279 Sales by Route of Administration
2.4.3.1 Global IMP4279 Sales Market Share by Route of Administration (2021-2026)
2.4.3.2 Global IMP4279 Revenue and Market Share by Route of Administration (2021-2026)
2.4.3.3 Global IMP4279 Sale Price by Route of Administration (2021-2026)
2.5 IMP4279 Segment by Sales Channels
2.5.1 Hospital
2.5.2 Retail
2.5.3 Online
2.5.4 IMP4279 Sales by Sales Channels
2.5.4.1 Global IMP4279 Sales Market Share by Sales Channels (2021-2026)
2.5.4.2 Global IMP4279 Revenue and Market Share by Sales Channels (2021-2026)
2.5.4.3 Global IMP4279 Sale Price by Sales Channels (2021-2026)
2.6 IMP4279 Segment by Application
2.6.1 Peripheral T-Cell Lymphoma (PTCL)
2.6.2 Relapsed Or Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
2.6.3 T-Cell Hematologic Malignancies
2.6.4 Others
2.6.5 IMP4279 Sales by Application
2.6.5.1 Global IMP4279 Sale Market Share by Application (2021-2026)
2.6.5.2 Global IMP4279 Revenue and Market Share by Application (2021-2026)
2.6.5.3 Global IMP4279 Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global IMP4279 Breakdown Data by Company
3.1.1 Global IMP4279 Annual Sales by Company (2021-2026)
3.1.2 Global IMP4279 Sales Market Share by Company (2021-2026)
3.2 Global IMP4279 Annual Revenue by Company (2021-2026)
3.2.1 Global IMP4279 Revenue by Company (2021-2026)
3.2.2 Global IMP4279 Revenue Market Share by Company (2021-2026)
3.3 Global IMP4279 Sale Price by Company
3.4 Key Manufacturers IMP4279 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IMP4279 Product Location Distribution
3.4.2 Players IMP4279 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IMP4279 BY GEOGRAPHIC REGION
4.1 World Historic IMP4279 Market Size by Geographic Region (2021-2026)
4.1.1 Global IMP4279 Annual Sales by Geographic Region (2021-2026)
4.1.2 Global IMP4279 Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic IMP4279 Market Size by Country/Region (2021-2026)
4.2.1 Global IMP4279 Annual Sales by Country/Region (2021-2026)
4.2.2 Global IMP4279 Annual Revenue by Country/Region (2021-2026)
4.3 Americas IMP4279 Sales Growth
4.4 APAC IMP4279 Sales Growth
4.5 Europe IMP4279 Sales Growth
4.6 Middle East & Africa IMP4279 Sales Growth
5 AMERICAS
5.1 Americas IMP4279 Sales by Country
5.1.1 Americas IMP4279 Sales by Country (2021-2026)
5.1.2 Americas IMP4279 Revenue by Country (2021-2026)
5.2 Americas IMP4279 Sales by Type (2021-2026)
5.3 Americas IMP4279 Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IMP4279 Sales by Region
6.1.1 APAC IMP4279 Sales by Region (2021-2026)
6.1.2 APAC IMP4279 Revenue by Region (2021-2026)
6.2 APAC IMP4279 Sales by Type (2021-2026)
6.3 APAC IMP4279 Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe IMP4279 by Country
7.1.1 Europe IMP4279 Sales by Country (2021-2026)
7.1.2 Europe IMP4279 Revenue by Country (2021-2026)
7.2 Europe IMP4279 Sales by Type (2021-2026)
7.3 Europe IMP4279 Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa IMP4279 by Country
8.1.1 Middle East & Africa IMP4279 Sales by Country (2021-2026)
8.1.2 Middle East & Africa IMP4279 Revenue by Country (2021-2026)
8.2 Middle East & Africa IMP4279 Sales by Type (2021-2026)
8.3 Middle East & Africa IMP4279 Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IMP4279
10.3 Manufacturing Process Analysis of IMP4279
10.4 Industry Chain Structure of IMP4279
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IMP4279 Distributors
11.3 IMP4279 Customer
12 WORLD FORECAST REVIEW FOR IMP4279 BY GEOGRAPHIC REGION
12.1 Global IMP4279 Market Size Forecast by Region
12.1.1 Global IMP4279 Forecast by Region (2027-2032)
12.1.2 Global IMP4279 Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global IMP4279 Forecast by Type (2027-2032)
12.7 Global IMP4279 Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Nanjing IMPACT Therapeutics
13.1.1 Nanjing IMPACT Therapeutics Company Information
13.1.2 Nanjing IMPACT Therapeutics IMP4279 Product Portfolios and Specifications
13.1.3 Nanjing IMPACT Therapeutics IMP4279 Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Nanjing IMPACT Therapeutics Main Business Overview
13.1.5 Nanjing IMPACT Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. IMP4279 Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. IMP4279 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 10mg
Table 4. Major Players of 50mg
Table 5. Global IMP4279 Sales by Type (2021-2026) & (Units)
Table 6. Global IMP4279 Sales Market Share by Type (2021-2026)
Table 7. Global IMP4279 Revenue by Type (2021-2026) & ($ million)
Table 8. Global IMP4279 Revenue Market Share by Type (2021-2026)
Table 9. Global IMP4279 Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Freeze-Dried Powder for Injection
Table 11. Major Players of Capsule
Table 12. Global IMP4279 Sales by Dosage Form (2021-2026) & (Units)
Table 13. Global IMP4279 Sales Market Share by Dosage Form (2021-2026)
Table 14. Global IMP4279 Revenue by Dosage Form (2021-2026) & ($ million)
Table 15. Global IMP4279 Revenue Market Share by Dosage Form (2021-2026)
Table 16. Global IMP4279 Sale Price by Dosage Form (2021-2026) & (US$/Unit)
Table 17. Major Players of Oral Administration
Table 18. Major Players of Intravenous Injection
Table 19. Global IMP4279 Sales by Route of Administration (2021-2026) & (Units)
Table 20. Global IMP4279 Sales Market Share by Route of Administration (2021-2026)
Table 21. Global IMP4279 Revenue by Route of Administration (2021-2026) & ($ million)
Table 22. Global IMP4279 Revenue Market Share by Route of Administration (2021-2026)
Table 23. Global IMP4279 Sale Price by Route of Administration (2021-2026) & (US$/Unit)
Table 24. Major Players of Hospital
Table 25. Major Players of Retail
Table 26. Major Players of Online
Table 27. Global IMP4279 Sales by Sales Channels (2021-2026) & (Units)
Table 28. Global IMP4279 Sales Market Share by Sales Channels (2021-2026)
Table 29. Global IMP4279 Revenue by Sales Channels (2021-2026) & ($ million)
Table 30. Global IMP4279 Revenue Market Share by Sales Channels (2021-2026)
Table 31. Global IMP4279 Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 32. Global IMP4279 Sale by Application (2021-2026) & (Units)
Table 33. Global IMP4279 Sale Market Share by Application (2021-2026)
Table 34. Global IMP4279 Revenue by Application (2021-2026) & ($ million)
Table 35. Global IMP4279 Revenue Market Share by Application (2021-2026)
Table 36. Global IMP4279 Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global IMP4279 Sales by Company (2021-2026) & (Units)
Table 38. Global IMP4279 Sales Market Share by Company (2021-2026)
Table 39. Global IMP4279 Revenue by Company (2021-2026) & ($ millions)
Table 40. Global IMP4279 Revenue Market Share by Company (2021-2026)
Table 41. Global IMP4279 Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers IMP4279 Producing Area Distribution and Sales Area
Table 43. Players IMP4279 Products Offered
Table 44. IMP4279 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global IMP4279 Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global IMP4279 Sales Market Share Geographic Region (2021-2026)
Table 49. Global IMP4279 Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global IMP4279 Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global IMP4279 Sales by Country/Region (2021-2026) & (Units)
Table 52. Global IMP4279 Sales Market Share by Country/Region (2021-2026)
Table 53. Global IMP4279 Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global IMP4279 Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas IMP4279 Sales by Country (2021-2026) & (Units)
Table 56. Americas IMP4279 Sales Market Share by Country (2021-2026)
Table 57. Americas IMP4279 Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas IMP4279 Sales by Type (2021-2026) & (Units)
Table 59. Americas IMP4279 Sales by Application (2021-2026) & (Units)
Table 60. APAC IMP4279 Sales by Region (2021-2026) & (Units)
Table 61. APAC IMP4279 Sales Market Share by Region (2021-2026)
Table 62. APAC IMP4279 Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC IMP4279 Sales by Type (2021-2026) & (Units)
Table 64. APAC IMP4279 Sales by Application (2021-2026) & (Units)
Table 65. Europe IMP4279 Sales by Country (2021-2026) & (Units)
Table 66. Europe IMP4279 Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe IMP4279 Sales by Type (2021-2026) & (Units)
Table 68. Europe IMP4279 Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa IMP4279 Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa IMP4279 Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa IMP4279 Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa IMP4279 Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of IMP4279
Table 74. Key Market Challenges & Risks of IMP4279
Table 75. Key Industry Trends of IMP4279
Table 76. IMP4279 Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. IMP4279 Distributors List
Table 79. IMP4279 Customer List
Table 80. Global IMP4279 Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global IMP4279 Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas IMP4279 Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas IMP4279 Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC IMP4279 Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC IMP4279 Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe IMP4279 Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe IMP4279 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa IMP4279 Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa IMP4279 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global IMP4279 Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global IMP4279 Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global IMP4279 Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global IMP4279 Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Nanjing IMPACT Therapeutics Basic Information, IMP4279 Manufacturing Base, Sales Area and Its Competitors
Table 95. Nanjing IMPACT Therapeutics IMP4279 Product Portfolios and Specifications
Table 96. Nanjing IMPACT Therapeutics IMP4279 Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Nanjing IMPACT Therapeutics Main Business
Table 98. Nanjing IMPACT Therapeutics Latest Developments
Table 1. IMP4279 Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. IMP4279 Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 10mg
Table 4. Major Players of 50mg
Table 5. Global IMP4279 Sales by Type (2021-2026) & (Units)
Table 6. Global IMP4279 Sales Market Share by Type (2021-2026)
Table 7. Global IMP4279 Revenue by Type (2021-2026) & ($ million)
Table 8. Global IMP4279 Revenue Market Share by Type (2021-2026)
Table 9. Global IMP4279 Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Freeze-Dried Powder for Injection
Table 11. Major Players of Capsule
Table 12. Global IMP4279 Sales by Dosage Form (2021-2026) & (Units)
Table 13. Global IMP4279 Sales Market Share by Dosage Form (2021-2026)
Table 14. Global IMP4279 Revenue by Dosage Form (2021-2026) & ($ million)
Table 15. Global IMP4279 Revenue Market Share by Dosage Form (2021-2026)
Table 16. Global IMP4279 Sale Price by Dosage Form (2021-2026) & (US$/Unit)
Table 17. Major Players of Oral Administration
Table 18. Major Players of Intravenous Injection
Table 19. Global IMP4279 Sales by Route of Administration (2021-2026) & (Units)
Table 20. Global IMP4279 Sales Market Share by Route of Administration (2021-2026)
Table 21. Global IMP4279 Revenue by Route of Administration (2021-2026) & ($ million)
Table 22. Global IMP4279 Revenue Market Share by Route of Administration (2021-2026)
Table 23. Global IMP4279 Sale Price by Route of Administration (2021-2026) & (US$/Unit)
Table 24. Major Players of Hospital
Table 25. Major Players of Retail
Table 26. Major Players of Online
Table 27. Global IMP4279 Sales by Sales Channels (2021-2026) & (Units)
Table 28. Global IMP4279 Sales Market Share by Sales Channels (2021-2026)
Table 29. Global IMP4279 Revenue by Sales Channels (2021-2026) & ($ million)
Table 30. Global IMP4279 Revenue Market Share by Sales Channels (2021-2026)
Table 31. Global IMP4279 Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 32. Global IMP4279 Sale by Application (2021-2026) & (Units)
Table 33. Global IMP4279 Sale Market Share by Application (2021-2026)
Table 34. Global IMP4279 Revenue by Application (2021-2026) & ($ million)
Table 35. Global IMP4279 Revenue Market Share by Application (2021-2026)
Table 36. Global IMP4279 Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global IMP4279 Sales by Company (2021-2026) & (Units)
Table 38. Global IMP4279 Sales Market Share by Company (2021-2026)
Table 39. Global IMP4279 Revenue by Company (2021-2026) & ($ millions)
Table 40. Global IMP4279 Revenue Market Share by Company (2021-2026)
Table 41. Global IMP4279 Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers IMP4279 Producing Area Distribution and Sales Area
Table 43. Players IMP4279 Products Offered
Table 44. IMP4279 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global IMP4279 Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global IMP4279 Sales Market Share Geographic Region (2021-2026)
Table 49. Global IMP4279 Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global IMP4279 Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global IMP4279 Sales by Country/Region (2021-2026) & (Units)
Table 52. Global IMP4279 Sales Market Share by Country/Region (2021-2026)
Table 53. Global IMP4279 Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global IMP4279 Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas IMP4279 Sales by Country (2021-2026) & (Units)
Table 56. Americas IMP4279 Sales Market Share by Country (2021-2026)
Table 57. Americas IMP4279 Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas IMP4279 Sales by Type (2021-2026) & (Units)
Table 59. Americas IMP4279 Sales by Application (2021-2026) & (Units)
Table 60. APAC IMP4279 Sales by Region (2021-2026) & (Units)
Table 61. APAC IMP4279 Sales Market Share by Region (2021-2026)
Table 62. APAC IMP4279 Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC IMP4279 Sales by Type (2021-2026) & (Units)
Table 64. APAC IMP4279 Sales by Application (2021-2026) & (Units)
Table 65. Europe IMP4279 Sales by Country (2021-2026) & (Units)
Table 66. Europe IMP4279 Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe IMP4279 Sales by Type (2021-2026) & (Units)
Table 68. Europe IMP4279 Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa IMP4279 Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa IMP4279 Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa IMP4279 Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa IMP4279 Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of IMP4279
Table 74. Key Market Challenges & Risks of IMP4279
Table 75. Key Industry Trends of IMP4279
Table 76. IMP4279 Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. IMP4279 Distributors List
Table 79. IMP4279 Customer List
Table 80. Global IMP4279 Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global IMP4279 Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas IMP4279 Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas IMP4279 Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC IMP4279 Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC IMP4279 Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe IMP4279 Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe IMP4279 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa IMP4279 Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa IMP4279 Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global IMP4279 Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global IMP4279 Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global IMP4279 Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global IMP4279 Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Nanjing IMPACT Therapeutics Basic Information, IMP4279 Manufacturing Base, Sales Area and Its Competitors
Table 95. Nanjing IMPACT Therapeutics IMP4279 Product Portfolios and Specifications
Table 96. Nanjing IMPACT Therapeutics IMP4279 Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Nanjing IMPACT Therapeutics Main Business
Table 98. Nanjing IMPACT Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Picture of IMP4279
Figure 2. IMP4279 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IMP4279 Sales Growth Rate 2021-2032 (Units)
Figure 7. Global IMP4279 Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. IMP4279 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. IMP4279 Sales Market Share by Country/Region (2025)
Figure 10. IMP4279 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 10mg
Figure 12. Product Picture of 50mg
Figure 13. Global IMP4279 Sales Market Share by Type in 2026
Figure 14. Global IMP4279 Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Freeze-Dried Powder for Injection
Figure 16. Product Picture of Capsule
Figure 17. Global IMP4279 Sales Market Share by Dosage Form in 2026
Figure 18. Global IMP4279 Revenue Market Share by Dosage Form (2021-2026)
Figure 19. Product Picture of Oral Administration
Figure 20. Product Picture of Intravenous Injection
Figure 21. Global IMP4279 Sales Market Share by Route of Administration in 2026
Figure 22. Global IMP4279 Revenue Market Share by Route of Administration (2021-2026)
Figure 23. Product Picture of Hospital
Figure 24. Product Picture of Retail
Figure 25. Product Picture of Online
Figure 26. Global IMP4279 Sales Market Share by Sales Channels in 2026
Figure 27. Global IMP4279 Revenue Market Share by Sales Channels (2021-2026)
Figure 28. IMP4279 Consumed in Peripheral T-Cell Lymphoma (PTCL)
Figure 29. Global IMP4279 Market: Peripheral T-Cell Lymphoma (PTCL) (2021-2026) & (Units)
Figure 30. IMP4279 Consumed in Relapsed Or Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
Figure 31. Global IMP4279 Market: Relapsed Or Refractory Peripheral T-Cell Lymphoma (R/R PTCL) (2021-2026) & (Units)
Figure 32. IMP4279 Consumed in T-Cell Hematologic Malignancies
Figure 33. Global IMP4279 Market: T-Cell Hematologic Malignancies (2021-2026) & (Units)
Figure 34. IMP4279 Consumed in Others
Figure 35. Global IMP4279 Market: Others (2021-2026) & (Units)
Figure 36. Global IMP4279 Sale Market Share by Application (2025)
Figure 37. Global IMP4279 Revenue Market Share by Application in 2025
Figure 38. IMP4279 Sales by Company in 2025 (Units)
Figure 39. Global IMP4279 Sales Market Share by Company in 2025
Figure 40. IMP4279 Revenue by Company in 2025 ($ millions)
Figure 41. Global IMP4279 Revenue Market Share by Company in 2025
Figure 42. Global IMP4279 Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global IMP4279 Revenue Market Share by Geographic Region in 2025
Figure 44. Americas IMP4279 Sales 2021-2026 (Units)
Figure 45. Americas IMP4279 Revenue 2021-2026 ($ millions)
Figure 46. APAC IMP4279 Sales 2021-2026 (Units)
Figure 47. APAC IMP4279 Revenue 2021-2026 ($ millions)
Figure 48. Europe IMP4279 Sales 2021-2026 (Units)
Figure 49. Europe IMP4279 Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa IMP4279 Sales 2021-2026 (Units)
Figure 51. Middle East & Africa IMP4279 Revenue 2021-2026 ($ millions)
Figure 52. Americas IMP4279 Sales Market Share by Country in 2025
Figure 53. Americas IMP4279 Revenue Market Share by Country (2021-2026)
Figure 54. Americas IMP4279 Sales Market Share by Type (2021-2026)
Figure 55. Americas IMP4279 Sales Market Share by Application (2021-2026)
Figure 56. United States IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC IMP4279 Sales Market Share by Region in 2025
Figure 61. APAC IMP4279 Revenue Market Share by Region (2021-2026)
Figure 62. APAC IMP4279 Sales Market Share by Type (2021-2026)
Figure 63. APAC IMP4279 Sales Market Share by Application (2021-2026)
Figure 64. China IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 68. India IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe IMP4279 Sales Market Share by Country in 2025
Figure 72. Europe IMP4279 Revenue Market Share by Country (2021-2026)
Figure 73. Europe IMP4279 Sales Market Share by Type (2021-2026)
Figure 74. Europe IMP4279 Sales Market Share by Application (2021-2026)
Figure 75. Germany IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 76. France IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 77. UK IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa IMP4279 Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa IMP4279 Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa IMP4279 Sales Market Share by Application (2021-2026)
Figure 83. Egypt IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of IMP4279 in 2026
Figure 89. Manufacturing Process Analysis of IMP4279
Figure 90. Industry Chain Structure of IMP4279
Figure 91. Channels of Distribution
Figure 92. Global IMP4279 Sales Market Forecast by Region (2027-2032)
Figure 93. Global IMP4279 Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global IMP4279 Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global IMP4279 Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global IMP4279 Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global IMP4279 Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of IMP4279
Figure 2. IMP4279 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IMP4279 Sales Growth Rate 2021-2032 (Units)
Figure 7. Global IMP4279 Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. IMP4279 Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. IMP4279 Sales Market Share by Country/Region (2025)
Figure 10. IMP4279 Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 10mg
Figure 12. Product Picture of 50mg
Figure 13. Global IMP4279 Sales Market Share by Type in 2026
Figure 14. Global IMP4279 Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Freeze-Dried Powder for Injection
Figure 16. Product Picture of Capsule
Figure 17. Global IMP4279 Sales Market Share by Dosage Form in 2026
Figure 18. Global IMP4279 Revenue Market Share by Dosage Form (2021-2026)
Figure 19. Product Picture of Oral Administration
Figure 20. Product Picture of Intravenous Injection
Figure 21. Global IMP4279 Sales Market Share by Route of Administration in 2026
Figure 22. Global IMP4279 Revenue Market Share by Route of Administration (2021-2026)
Figure 23. Product Picture of Hospital
Figure 24. Product Picture of Retail
Figure 25. Product Picture of Online
Figure 26. Global IMP4279 Sales Market Share by Sales Channels in 2026
Figure 27. Global IMP4279 Revenue Market Share by Sales Channels (2021-2026)
Figure 28. IMP4279 Consumed in Peripheral T-Cell Lymphoma (PTCL)
Figure 29. Global IMP4279 Market: Peripheral T-Cell Lymphoma (PTCL) (2021-2026) & (Units)
Figure 30. IMP4279 Consumed in Relapsed Or Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
Figure 31. Global IMP4279 Market: Relapsed Or Refractory Peripheral T-Cell Lymphoma (R/R PTCL) (2021-2026) & (Units)
Figure 32. IMP4279 Consumed in T-Cell Hematologic Malignancies
Figure 33. Global IMP4279 Market: T-Cell Hematologic Malignancies (2021-2026) & (Units)
Figure 34. IMP4279 Consumed in Others
Figure 35. Global IMP4279 Market: Others (2021-2026) & (Units)
Figure 36. Global IMP4279 Sale Market Share by Application (2025)
Figure 37. Global IMP4279 Revenue Market Share by Application in 2025
Figure 38. IMP4279 Sales by Company in 2025 (Units)
Figure 39. Global IMP4279 Sales Market Share by Company in 2025
Figure 40. IMP4279 Revenue by Company in 2025 ($ millions)
Figure 41. Global IMP4279 Revenue Market Share by Company in 2025
Figure 42. Global IMP4279 Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global IMP4279 Revenue Market Share by Geographic Region in 2025
Figure 44. Americas IMP4279 Sales 2021-2026 (Units)
Figure 45. Americas IMP4279 Revenue 2021-2026 ($ millions)
Figure 46. APAC IMP4279 Sales 2021-2026 (Units)
Figure 47. APAC IMP4279 Revenue 2021-2026 ($ millions)
Figure 48. Europe IMP4279 Sales 2021-2026 (Units)
Figure 49. Europe IMP4279 Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa IMP4279 Sales 2021-2026 (Units)
Figure 51. Middle East & Africa IMP4279 Revenue 2021-2026 ($ millions)
Figure 52. Americas IMP4279 Sales Market Share by Country in 2025
Figure 53. Americas IMP4279 Revenue Market Share by Country (2021-2026)
Figure 54. Americas IMP4279 Sales Market Share by Type (2021-2026)
Figure 55. Americas IMP4279 Sales Market Share by Application (2021-2026)
Figure 56. United States IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC IMP4279 Sales Market Share by Region in 2025
Figure 61. APAC IMP4279 Revenue Market Share by Region (2021-2026)
Figure 62. APAC IMP4279 Sales Market Share by Type (2021-2026)
Figure 63. APAC IMP4279 Sales Market Share by Application (2021-2026)
Figure 64. China IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 68. India IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe IMP4279 Sales Market Share by Country in 2025
Figure 72. Europe IMP4279 Revenue Market Share by Country (2021-2026)
Figure 73. Europe IMP4279 Sales Market Share by Type (2021-2026)
Figure 74. Europe IMP4279 Sales Market Share by Application (2021-2026)
Figure 75. Germany IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 76. France IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 77. UK IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa IMP4279 Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa IMP4279 Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa IMP4279 Sales Market Share by Application (2021-2026)
Figure 83. Egypt IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries IMP4279 Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of IMP4279 in 2026
Figure 89. Manufacturing Process Analysis of IMP4279
Figure 90. Industry Chain Structure of IMP4279
Figure 91. Channels of Distribution
Figure 92. Global IMP4279 Sales Market Forecast by Region (2027-2032)
Figure 93. Global IMP4279 Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global IMP4279 Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global IMP4279 Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global IMP4279 Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global IMP4279 Revenue Market Share Forecast by Application (2027-2032)
